Estatísticas Básicas
| LEI | 549300KKBM83T87VHO35 |
| CIK | 1839285 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Healthcare Triangle, Inc.
SEC Filings (Chronological Order)
Esta página fornece uma lista completa e cronológica de Arquivamentos da SEC, excluindo os arquivamentos de propriedade que fornecemos em outro lugar.
| May 14, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC |
|
| May 14, 2026 |
LIST OF SUBSIDIAIRIES OF THE REGISTRANT Exhibit 21.1 LIST OF SUBSIDIAIRIES OF THE REGISTRANT 1. Devcool Inc. 2. QuantumNexis Inc. 3. QuantumNexis Malaysia (SDN) BHD. 4. Ezovion Solutions (Private) Limited 5. Teyame AI Holdings Inc. 6. Teyame 360 S.L. 7. Datono Mediacion S.L. 8. Purpose Health Inc. |
|
| April 16, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-409 |
|
| April 15, 2026 |
Exhibit 21.1 LIST OF SUBSIDIARIES 1. Devcool Inc. 2. QuantumNexis Inc. 3. QUANTUMNEXIS SDN. BHD. 4. Ezovion Solutions Private Limited 5. Teyame Al Holdings Inc. |
|
| April 15, 2026 |
Exhibit 4.4 DESCRIPTION OF CAPITAL STOCK General The following description summarizes the most important terms of our capital stock. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth in this “Description of Capital Stock,” you should refer to our amended and restated certificate of incorporation, |
|
| April 15, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40903 HEALTHCARE TRIANG |
|
| April 10, 2026 |
PLATFORM DEVELOPMENT AGREEMENT Exhibit 10.1 PLATFORM DEVELOPMENT AGREEMENT Between Healthcare Triangle, Inc., SecureKloud Technologies Limited and Blockedge Technologies Inc. Dated: April 7th 2026 This Agreement is entered into by and between Healthcare Triangle, Inc., a Delaware corporation (“HCTI”), SecureKloud Technologies Limited, an Indian corporation (“SKL”) as the Lead Contractor, and Blockedge Technologies Inc., a subsi |
|
| April 10, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2026 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| April 7, 2026 |
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 99.3 KPSN & Associates LLP Chartered Accountants REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Teyame AI LLC. Opinion on the Financial Statements We have audited the accompanying balance sheet of Datono Mediacion, S.L., a company incorporated in Spain (the Company) as of December 31, 2025, and the related statement of operations, chan |
|
| April 7, 2026 |
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 99.2 KPSN & Associates LLP Chartered Accountants REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Teyame AI LLC. Opinion on the Financial Statements We have audited the accompanying balance sheet of Teyame 360, S.L., a company incorporated in Spain (the Company) as of December 31, 2025, and the related statement of operations, changes in |
|
| April 7, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2026 (January 22, 2026) HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jur |
|
| April 7, 2026 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The unaudited pro forma condensed combined financial data should be read in conjunction with the historical financial statements and the accompanying notes of Healthcare Triangle, Inc., and the standalone financial statements of Teyame 360 SL and Datono Mediacion SL respectively, filed herewith. The unaudited pro forma infor |
|
| March 31, 2026 |
HEALTHCARE TRIANGLE, INC. Up to $39,000,000 Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-276382 PROSPECTUS SUPPLEMENT (to Prospectus Supplement dated November 19, 2025 to Prospectus dated January 31, 2024) HEALTHCARE TRIANGLE, INC. Up to $39,000,000 Common Stock This prospectus supplement (the “Prospectus Supplement”) amends and supplements the prospectus supplement dated November 19, 2025, and its accompanying base prospectus date |
|
| March 31, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-K ☐ Transition Report o |
|
| March 11, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2026 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissio |
|
| March 11, 2026 |
Healthcare Triangle, Inc. Announces Approval of $2 Million Share Repurchase Plan Exhibit 99.1 Healthcare Triangle, Inc. Announces Approval of $2 Million Share Repurchase Plan PLEASANTON, Calif., March 11, 2026 (PRNEWSWIRE) — Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announces that its Boar |
|
| February 27, 2026 |
Exhibit 10.2 February 26, 2026 D. Boral Capital LLC 590 Madison Avenue, 39th Floor New York, New York 10022 Ladies and Gentlemen: Subject to the terms and conditions herein (this “Agreement”), HEALTHCARE TRIANGLE, INC., a Delaware corporation (the “Company”), hereby agrees to sell up to an aggregate of 681,553 shares (the “Shares”) of the Company’s common stock, $0.00001 par value per share (the “ |
|
| February 27, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2026 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commis |
|
| February 27, 2026 |
421,553 Shares of Common Stock Pre-Funded Warrants to Purchase 260,000 Shares of Common Stock Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-276382 Prospectus Supplement (To Prospectus dated January 31, 2024) 421,553 Shares of Common Stock Pre-Funded Warrants to Purchase 260,000 Shares of Common Stock We are offering 421,553 shares of our common stock, par value $0.00001 per share, at a public offering price of $5.81 per share to certain institutional investors pursuant to |
|
| February 27, 2026 |
Exhibit 99.1 Healthcare Triangle Announces Approximately $3.959 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules PLEASANTON, Calif., February 26, 2026 (PR NEWSWIRE) — Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions for healthcare and life sciences, today announced today that it has entered i |
|
| February 27, 2026 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of February 26, 2026, by and between HEALTHCARE TRIANGLE, INC., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). RECITA |
|
| February 27, 2026 |
FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT HEALTHCARE TRIANGLE, INC. Exhibit 4.1 FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT HEALTHCARE TRIANGLE, INC. Warrant Shares: Initial Exercise Date: February 27, 2026 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on |
|
| February 13, 2026 |
Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan Exhibit 99.1 Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan PLEASANTON, Calif., February 6, 2026 (GLOBENEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today an |
|
| February 13, 2026 |
CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION HEALTHCARE TRIANGLE, INC. Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF HEALTHCARE TRIANGLE, INC. Healthcare Triangle, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: 1. Pursuant to Section 242 of the DGCL, this Certificate of Amendment to the Amended Certificate of Inc |
|
| February 13, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2026 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commis |
|
| February 6, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2026 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| January 28, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2026 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| January 20, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| January 9, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| December 16, 2025 |
Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 December 16, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Matthew Derby Re: Healthcare Triangle, Inc. Request for Acceleration Registration Statement on Form S-3 File No. 333-291838 Ladies and Gentlemen: Pursuant to Rule |
|
| December 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| December 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commis |
|
| November 28, 2025 |
As filed with the Securities and Exchange Commission on November 28, 2025 As filed with the Securities and Exchange Commission on November 28, 2025 Registration No. |
|
| November 28, 2025 |
Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-3 Healthcare Triangle, Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Common Stoc |
|
| November 25, 2025 |
HEALTHCARE TRIANGLE, INC. 1,458,118 Shares of Common Stock Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-290914 Prospectus HEALTHCARE TRIANGLE, INC. 1,458,118 Shares of Common Stock This prospectus relates to the offer and resale of (a) up to an aggregate of 1,429,528 shares of common stock, par value $0.00001 per share (“Common Stock”), of Healthcare Triangle, Inc., a Delaware corporation (the “Company”, “we”, “us” or “our”), issuable u |
|
| November 21, 2025 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of November 20, 2025, by and between Healthcare Triangle, Inc., a corporation incorporated under the laws of the State of Delaware (the “Company”), and each investor identified on the signature pages hereto (each, |
|
| November 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commis |
|
| November 21, 2025 |
Healthcare Triangle, Inc. Convertible Promissory Note Exhibit 4.1 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION S |
|
| November 21, 2025 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of November 20, 2025, among HEALTHCARE TRIANGLE, INC., a corporation incorporated under the laws of the State of Delaware (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” or “Holder” and, collectively, the “Purchasers”) |
|
| November 20, 2025 |
Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 November 20, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Jan Wu Re: Healthcare Triangle, Inc. Request for Acceleration Registration Statement on Form S-3 File No. 333-276382 Ladies and Gentlemen: Pursuant to Rule 461 pro |
|
| November 19, 2025 |
Healthcare Triangle, Inc. COMMON STOCK SALES AGREEMENT Exhibit 1.1 EXECUTION VERSION Healthcare Triangle, Inc. COMMON STOCK SALES AGREEMENT November 18, 2025 Spartan Capital Securities, LLC 45 Broadway, 19th Floor New York, NY 10006 Ladies and Gentlemen: Healthcare Triangle, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Spartan Capital Securities, LLC (the “Sales Agent”), as follows: 1. Issuance and Sale |
|
| November 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commis |
|
| November 19, 2025 |
Up to $20,000,000 Healthcare Triangle, Inc. Common Stock Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-276382 Prospectus Supplement (To Prospectus dated January 31, 2024) Up to $20,000,000 Healthcare Triangle, Inc. Common Stock We may offer to sell up to $20,000,000 in the aggregate of our shares of common stock, $0.00001 per share from time to time pursuant to this prospectus supplement through Spartan Capital Securities, LLC, which w |
|
| November 19, 2025 |
As filed with the Securities and Exchange Commission on November 19, 2025 As filed with the Securities and Exchange Commission on November 19, 2025 Registration No. |
|
| November 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| November 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, |
|
| November 13, 2025 |
LIST OF SUBSIDIAIRIES OF THE REGISTRANT Exhibit 21.1 LIST OF SUBSIDIAIRIES OF THE REGISTRANT 1. Devcool, Inc. 2. QuantumNexis, Inc. 3. QuantumNexis Malaysia (SDN) BHD 4. Ezovion Solutions (Private) Limited |
|
| November 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 7, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi |
|
| November 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| October 16, 2025 |
As filed with the Securities and Exchange Commission on October 16, 2025 As filed with the Securities and Exchange Commission on October 16, 2025 Registration No. |
|
| October 16, 2025 |
Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-3 Healthcare Triangle, Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Common Stoc |
|
| October 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| October 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information S |
|
| October 8, 2025 |
Exhibit 99.2 Healthcare Triangle Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $755,000 PLEASANTON, Calif., October 03, 2025 (PR NEWSWIRE) — Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leading provider of capital markets and institutional execution services, announced today that Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company” |
|
| October 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 2, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissio |
|
| October 8, 2025 |
Exhibit 10.1 HEALTHCARE TRIANGLE, INC. October 2, 2025 To: Holder of Common Share Purchase Warrants Re: Inducement Offer and Agreement to Exercise Common Share Purchase Warrants Dear Holder: Healthcare Triangle, Inc., a Delaware corporation (the “Company”), is pleased to offer to you the opportunity to exercise the [*] Common Stock Purchase Warrants issued to you on February 28, 2025 (with a curre |
|
| October 8, 2025 |
FORM OF ADVISORY WARRANT HEALTHCARE TRIANGLE, INC. Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| October 8, 2025 |
Exhibit 99.1 Update - Healthcare Triangle Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $1.63 Million PLEASANTON, Calif., October 02, 2025 (PR NEWSWIRE) — Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions for healthcare and life sciences, today announced today it has entered into warrant exercise agreements |
|
| October 8, 2025 |
FORM OF COMMON STOCK PURCHASE WARRANT HEALTHCARE TRIANGLE, INC. Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| October 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information S |
|
| September 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| September 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 15, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commis |
|
| September 15, 2025 |
Exhibit 99.1 1 Healthcare Triangle, Inc. (NASDAQ: HCTI) Transforming Healthcare Through EHR, Cloud, and A.I. Driving Growth, Building Value 2 Forward - Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 . These statements are based on current expectations, estimates, forecasts, and projections about |
|
| September 2, 2025 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The unaudited pro forma condensed combined financial data should be read in conjunction with the historical financial statements and the accompanying notes of Healthcare Triangle, Inc. included in its Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) on March 30, 2025 and Quarterly Reports on |
|
| September 2, 2025 |
Exhibit 99.1 |
|
| September 2, 2025 |
Exhibit 99.2 |
|
| September 2, 2025 |
AMENDMENT NO. 1 TO ASSET TRANSFER AGREEMENT Exhibit 10.1 AMENDMENT NO. 1 TO ASSET TRANSFER AGREEMENT This Amendment No. 1 (the “Amendment) dated as of August 28, 2025 is entered into among Niyama Healthcare, Inc., a Delaware corporation (the “Seller”), and Healthcare Triangle, Inc., a Delaware corporation (the “Purchaser). Seller, and the Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” |
|
| September 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2025 (June 16, 2025) HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other juri |
|
| August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC. |
|
| August 1, 2025 |
Certificate of Amendment to Certificate of Incorporation of Healthcare Triangle, Inc. Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF HEALTHCARE TRIANGLE, INC. Healthcare Triangle, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: 1. Pursuant to Section 242 of the DGCL, this Certificate of Amendment to the Amended Certificate of Inc |
|
| August 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 30, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| August 1, 2025 |
Healthcare Triangle, Inc. Announces 1-for-249 Reverse Stock Split as Part of Nasdaq Compliance Plan Exhibit 99.1 Healthcare Triangle, Inc. Announces 1-for-249 Reverse Stock Split as Part of Nasdaq Compliance Plan PLEASANTON, Calif., July 30, 2025 (GLOBENEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today anno |
|
| August 1, 2025 |
Exhibit 3.2 CERTIFICATE OF CORRECTION TO THE CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HEALTHCARE TRIANGLE, INC. Healthcare Triangle, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: 1. The name of the corporation is Healthcare Tria |
|
| July 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 2, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F |
|
| July 7, 2025 |
Exhibit 99.1 Healthcare Triangle, Inc. Announces Nasdaq Hearings Panel’s Grant of the Company’s Request for Continued Listing of its Securities. Pleasanton, California, July 7, 2025. (NewsMediaWire) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a visionary leader in digital transformation solutions for the healthcare and life sciences industries, today announced today annou |
|
| June 23, 2025 |
Exhibit 10.1 ASSET and STOCK TRANSFER AGREEMENT June 16, 2025 ASSET TRANSFER AGREEMENT This ASSET and STOCK TRANSFER AGREEMENT (the “Agreement”) is entered into as of June 16, 2025 (“Execution Date”) by and between: (1) Niyama Healthcare, Inc., a Delaware corporation, having its registered office at 8 The Green, #21863, Dover, DE 19901, USA (the “Seller” which expression shall unless repugnant to |
|
| June 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 16, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| June 23, 2025 |
Healthcare Triangle Completes Strategic Acquisition of Niyama Healthcare and Ezovion Solutions Exhibit 99.1 Healthcare Triangle Completes Strategic Acquisition of Niyama Healthcare and Ezovion Solutions Pleasanton, California, June 16, 2025. (NewMediaWire) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the "Company"), a visionary leader in digital transformation solutions for the healthcare and life sciences industries, today announced the successful closing of its acquisition of the |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 30, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F |
|
| May 23, 2025 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 20, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F |
|
| May 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC |
|
| May 15, 2025 |
HEALTHCARE TRIANGLE, INC. Up to 1,483,809,885 Shares of Common Stock Filed Pursuant to Rule 424(b)(4) Registration No. 333-286331 HEALTHCARE TRIANGLE, INC. Up to 1,483,809,885 Shares of Common Stock This prospectus relates to the offer and sale from time to time of up to 1,483,809,885 shares of common stock, par value $0.00001 per share (the “Common Stock”) of Healthcare Triangle, Inc., (either individually or together with its subsidiaries, “us, “we”, “our”, “HCTI |
|
| May 13, 2025 |
7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 May 13, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Aliya Ishmukhamedova / Matthew Crispino Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333-286331 Ladies and Gentlemen: Purs |
|
| May 13, 2025 |
Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 May 13, 2025 Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 May 13, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Aliya Ishmukhamedova / Matthew Crispino Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333-286331 Ladies and Gentlemen: Purs |
|
| May 13, 2025 |
Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 May 13, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Aliya Ishmukhamedova / Matthew Crispino Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333-286331 Ladies and Gentlemen: Reference is |
|
| May 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: 3/31/2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: n/a Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| May 9, 2025 |
As filed with the Securities and Exchange Commission on May 8, 2025 As filed with the Securities and Exchange Commission on May 8, 2025 Registration No. |
|
| May 8, 2025 |
May 8, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F. Street, NE Washington, D.C. 20549 Attention: Aliya Ishmukhamedova / Matthew Crispino Re: Healthcare Triangle, Inc. Amendment No. 2 to Registration Statement on Form S-1 Originally Submitted on April 1, 2025 File No. 333-286331 Ladies and Gentlemen: On behalf of Healthcare Trian |
|
| May 5, 2025 |
May 5, 2025 David Ayanoglou Chief Financial Officer Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 Re: Healthcare Triangle, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed April 22, 2025 File No. 333-286331 Dear David Ayanoglou: We have reviewed your amended registration statement and have the following comments. Please respond to this letter by am |
|
| April 22, 2025 |
As filed with the Securities and Exchange Commission on April 22, 2025 As filed with the Securities and Exchange Commission on April 22, 2025 Registration No. |
|
| April 22, 2025 |
April 22, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F. Street, NE Washington, D.C. 20549 Attention: Aliya Ishmukhamedova / Matthew Crispino Re: Healthcare Triangle, Inc. Amendment No. 1 to Registration Statement on Form S-1 Submitted April 1, 2025 File No. 333-286331 Ladies and Gentlemen: On behalf of Healthcare Triangle, Inc. ( |
|
| April 15, 2025 |
April 15, 2025 David Ayanoglou Chief Financial Officer Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 Re: Healthcare Triangle, Inc. Registration Statement on Form S-1 Filed April 1, 2025 File No. 333-286331 Dear David Ayanoglou: We have conducted a limited review of your registration statement and have the following comments. Please respond to this letter by amendi |
|
| April 11, 2025 |
Exhibit 16.1 April 11, 2025 Securities and Exchange Commission Office of the Chief Accountant 100 F Street N.E. Washington, D.C. 20549 Re: Healthcare Triangle, Inc. File Ref. No. 001-40903 We have read the statements made by Healthcare Triangle, Inc., which we understand will be filed by the Commission, pursuant to Item 4.01 of Form 8-K, as part of Healthcare Triangle, Inc. Form 8-K report dated A |
|
| April 11, 2025 |
Exhibit 10.1 Employment Agreement THIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between HEALTHCARE TRIANGLE INC. a Delaware limited liability company (the “Company”) and DAVID AYANOGLOU (the “Employee”) is signed by the Company and the Employee on 10th April 2025 (the “Effective Date”). Background The Board of Directors of the Company (the “Board”) has determined that it is in the best inter |
|
| April 11, 2025 |
Healthcare Triangle announces the appointment of Chief Financial Officer and Director on the Board. Exhibit 99.1 Healthcare Triangle announces the appointment of Chief Financial Officer and Director on the Board. PLEASANTON, Calif., April 11th , 2025 (NEWMEDIAWIRE) - Healthcare Triangle, Inc (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, data analytics, and AI for the healthcare and life sciences |
|
| April 11, 2025 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 10, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| April 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 8, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| April 2, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 28, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| April 1, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Healthcare Triangle, Inc. |
|
| April 1, 2025 |
As filed with the Securities and Exchange Commission on April 1, 2025 As filed with the Securities and Exchange Commission on April 1, 2025 Registration No. |
|
| March 31, 2025 |
Exhibit 4.4 DESCRIPTION OF CAPITAL STOCK General The following description summarizes the most important terms of our capital stock. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth in this “Description of Capital Stock,” you should refer to our amended and restated certificate of incorporation, |
|
| March 31, 2025 |
Exhibit 4.5 THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABL |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40903 HEALTHCARE TRIANG |
|
| March 24, 2025 |
Exhibit 10.1 Employment Agreement THIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between HEALTHCARE TRIANGLE INC. a Delaware limited liability company (the “Company”) and SUJATHA RAMESH (the “Employee”) is signed by the Company and the Employee on March 18, 2025 (the “Effective Date”). Background The Board of Directors of the Company (the “Board”) has determined that it is in the best interes |
|
| March 24, 2025 |
Healthcare Triangle announces the appointment of Chief Operating Officer Exhibit 99.1 Healthcare Triangle announces the appointment of Chief Operating Officer PLEASANTON, Calif., March 18, 2025 (GLOBENEWSWIRE) - Healthcare Triangle, Inc (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, data analytics, and AI for the healthcare and life sciences industries, today announced |
|
| March 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 18, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| March 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted b |
|
| March 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| March 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement HEALTHCARE TRIANGLE, INC. (Name of Registra |
|
| March 3, 2025 |
Exhibit 4.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| March 3, 2025 |
Healthcare Triangle, Inc Announces Closing of $15.2 Million PIPE Offering Exhibit 99.2 Healthcare Triangle, Inc Announces Closing of $15.2 Million PIPE Offering PLEASANTON, CA - February 28, 2025 (NEWMEDIAWIRE) - Healthcare Triangle, Inc (NASDAQ: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions, including managed services, cloud enablement, cybersecurity, and data analytics for the healthcare and life sciences industries, today announced the |
|
| March 3, 2025 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 27, 2025, between Healthcare Triangle, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pursuant to the Securities Pu |
|
| March 3, 2025 |
Healthcare Triangle, Inc Announces $15.2 Million PIPE Offering. Exhibit 99.1 Healthcare Triangle, Inc Announces $15.2 Million PIPE Offering. Healthcare Triangle, Inc (NASDAQ: HCTI) (“HCTI” or the “Company”), PLEASANTON, Calif., February 27, 2025 (GLOBENEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, and data analytics for the |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| March 3, 2025 |
Exhibit 4.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| March 3, 2025 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 27, 2025, between Healthcare Triangle, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the te |
|
| March 3, 2025 |
Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| February 27, 2025 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 26, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| February 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| February 18, 2025 |
Letter of M&K CPAS, PLLC dated February 14, 2025 Exhibit 16.1 February 14, 2025 Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Ladies and Gentlemen: We have read the statements made by Healthcare Triangle, Inc. (the “Company”), set forth in Item 4.02 of the Company’s Current Report on Form 8-K, dated February 14, 2025 (the “Form 8-K”). We agree with the statements concerning our Firm contained in such Item 4.02. Very tru |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40903 |
|
| February 18, 2025 |
Exhibit 4.4 HEALTHCARE TRIANGLE, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the common stock of Healthcare Triangle, Inc. (the “Company,” “we,” “our,” or “us”), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commis |
|
| January 21, 2025 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 14, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 4, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi |
|
| December 3, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 21, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of inco |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, |
|
| October 25, 2024 |
Exhibit 3.1 HEALTHCARE TRIANGLE, INC. CERTIFICATE OF DESIGNATIONS, RIGHTS AND PREFERENCES OF SERIES B CONVERTIBLE PREFERRED STOCK Pursuant to Section 151 of the Delaware General Corporation Law, Healthcare Triangle, Inc., a Delaware corporation (the “Corporation”), DOES HEREBY CERTIFY: WHEREAS, the Amended and Restated Certificate of Incorporation of the Corporation, as amended (the “Certificate o |
|
| October 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 21, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi |
|
| October 25, 2024 |
Exhibit 10.1 ASSET TRANSFER AGREEMENT October 21, 2024 ASSET TRANSFER AGREEMENT This ASSET TRANSFER AGREEMENT (the “Agreement”) is entered into as of October 21, 2024 (“Execution Date”) by and between: (1) SecureKloud Technologies, Inc ., a Nevada corporation, having its registered office at 666 Plainsboro Road, Suite 448, Plainsboro, NJ 08536, USA (the “Seller” which expression shall unless repug |
|
| September 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 4, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| September 6, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 3, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| August 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement HEALTHCARE TRIANGLE, INC. (Name |
|
| August 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC. |
|
| August 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: 6/30/2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: n/a Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| June 27, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 26, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: 3/31/2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: n/a Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| May 13, 2024 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 8, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 6, 2024 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 22, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 20, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| March 18, 2024 |
Exhibit 4.4 HEALTHCARE TRIANGLE, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the common stock of Healthcare Triangle, Inc. (the “Company,” “we,” “our,” or “us”), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the |
|
| March 18, 2024 |
Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO Exhibit 99.1 Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO PLEASANTON, Calif., March 12, 2024 - Healthcare Triangle Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a frontrunner in healthcare technology has announced the appointment of Anand Kumar as the interim Chief Executive Officer alongside his current role as the Chief Revenue Officer. Anand is committed |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40903 HEALTHCARE TRIANG |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 12, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| March 18, 2024 |
Offer Letter, dated March 14, 2024, between Healthcare Triangle, Inc. and Anand Kumar. Exhibit 10.1 3/14/2024 Anand Kumar Healthcare Triangle, Inc. (HCTI) is pleased to offer you the role of interim CEO. Itemized below are the proposed terms of our offer: 1. As interim CEO and a full time, permanent employee, your base salary will be $240,000 per year. 2. As a full time, permanent employee, you will be entitled to participate in our Unlimited Vacation Policy. You are also entitled t |
|
| February 13, 2024 |
Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 February 13, 2024 Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 February 13, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Charli Gibbs-Tabler/Matthew Derby Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333-276501 Ladies and Gentlemen: P |
|
| February 12, 2024 |
As filed with the Securities and Exchange Commission on February 12, 2024 As filed with the Securities and Exchange Commission on February 12, 2024 Registration No. |
|
| February 9, 2024 |
February 9, 2024 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F. Street, NE Washington, D.C. 20549 Attention: Charli Gibbs-Tabler / Matthew Derby Re: Healthcare Triangle, Inc. Amendment No. 1 to Registration Statement on Form S-1 Submitted January 12, 2024 CIK No. 0001839285 Ladies and Gentlemen: On behalf of Healthcare Triangle, Inc |
|
| February 9, 2024 |
Exhibit 10.23 |
|
| February 9, 2024 |
As filed with the Securities and Exchange Commission on February 9, 2024 As filed with the Securities and Exchange Commission on February 9, 2024 Registration No. |
|
| February 2, 2024 |
Exhibit 99.1 January 30, 2024 Devcool Inc 5890 Stoneridge Dr #107 Pleasanton, CA 94588 RE: Termination of Staffing Company Agreement between Guidant Global, Inc. and Devcool Inc Dear Supplier: The purpose of this letter is to provide Devcool Inc (“Supplier”) with notice of Guidant Global Inc.’s (“Guidant”) termination of the Supplier Master Services Agreement entered into between Guidant and Suppl |
|
| February 2, 2024 |
Termination of a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 30, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi |
|
| February 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 1, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction (Commission File Number) (I |
|
| February 1, 2024 |
Exhibit 99.1 February 1, 2024 To Dave Rosa Chairman of the Board Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite # 220, Pleasanton CA, USA 94588 Dear Dave, I would like to notify you and the rest of the Board that I have decided to step down from the Board of Director position with Healthcare Triangle, Inc. effective February 01st 2024 due to personal time commitments. Thank you for all the |
|
| January 29, 2024 |
Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 January 29, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Charli Gibbs-Tabler Re: Healthcare Triangle, Inc. Request for Acceleration Registration Statement on Form S-3 File No. 333-276382 Ladies and Gentlemen: Pursuant to |
|
| January 26, 2024 |
United States securities and exchange commission logo January 26, 2024 Thyagarajan Ramachandran Chief Financial Officer Healthcare Triangle, Inc. |
|
| January 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information S |
|
| January 16, 2024 |
As filed with the Securities and Exchange Commission on January 16, 2024 As filed with the Securities and Exchange Commission on January 16, 2024 Registration No. |
|
| January 16, 2024 |
Form of Subordinated Indenture Exhibit 4.3 HEALTHCARE TRIANGLE, INC. as the Company and as Trustee Subordinated Indenture Dated as of , 20 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 4 Section 1.01. Definitions 4 Section 1.02. Other Definitions 8 Section 1.03. Incorporation by Reference of Trust Indenture Act 8 Section 1.04. Rules of Construction 8 ARTICLE 2 THE SECURITIES 9 Section 2.01. Form an |
|
| January 16, 2024 |
Exhibit 4.2 HEALTHCARE TRIANGLE, INC. as the Company and as Trustee Senior Indenture Dated as of , 20 1 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 5 Section 1.01. Definitions 5 Section 1.02. Other Definitions 9 Section 1.03. Incorporation by Reference of Trust Indenture Act 9 Section 1.04. Rules of Construction 10 ARTICLE 2 THE SECURITIES 10 Section 2.01. Form and |
|
| January 16, 2024 |
United States securities and exchange commission logo January 16, 2024 Thyagarajan Ramachandran Chief Financial Officer Healthcare Triangle, Inc. |
|
| January 12, 2024 |
As filed with the Securities and Exchange Commission on January 12, 2024 As filed with the Securities and Exchange Commission on January 12, 2024 Registration No. |
|
| January 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2024 (December 28, 2023) HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other |
|
| January 12, 2024 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) HEALTHCARE TRIANGLE, INC. |
|
| January 12, 2024 |
Form of Senior Secured 15% Original Issue Discount Convertible Promissory Note.* Exhibit 4.1 THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABL |
|
| January 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information S |
|
| January 5, 2024 |
ATM Sales Agreement, dated January 4, 2024 between the Registrant and Dawson James Securities, Inc. HEALTHCARE TRIANGLE, INC. COMMON STOCK ATM SALES AGREEMENT January 4, 2024 Dawson James Securities, Inc. 101 North Federal Highway Suite 600 Boca Raton, Fl 33432 Ladies and Gentlemen: Healthcare Triangle, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Dawson James Securities, Inc., as follows: 1. Issuance and Sale of Shares. The Company agrees that, fr |
|
| January 5, 2024 |
Calculation of Filing Fee Tables S-3 (Form Type) Healthcare Triangle, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Share (2) Maximum Aggregate Offering Price( Fee Rate Amount of Registration Fee Fees |
|
| January 5, 2024 |
As filed with the Securities and Exchange Commission on January 4, 2024 As filed with the Securities and Exchange Commission on January 4, 2024 Registration No. |
|
| January 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-409 |
|
| January 2, 2024 |
INTERCREDITOR AGREEMENT THIS AGREEMENT made and entered into this 28th day of December 2023 by and among SEACOAST BUSINESS FUNDING, a division of Seacoast National Bank with a place of business at 1880 N Congress Ave. |
|
| January 2, 2024 |
FORM OF SUBSIDIARY GUARANTEE This SUBSIDIARY GUARANTEE (as amended, restated, supplemented, or otherwise modified and in effect from time to time, this “Guarantee”) is made as of December 28, 2023, jointly and severally, between Healthcare Triangle, Inc. |
|
| January 2, 2024 |
Healthcare Triangle, Inc. Completes $2.0 Million Private Placement Debt Offering Healthcare Triangle, Inc. Completes $2.0 Million Private Placement Debt Offering PLEASANTON, Calif., January 2, 2024 (GLOBENEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, data analytics, and AI data processing for the healthcare and life s |
|
| January 2, 2024 |
REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is dated as of December 28, 2023, by and among Healthcare Triangle, Inc. |
|
| January 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 28, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| January 2, 2024 |
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEM |
|
| January 2, 2024 |
SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 28, 2023, between Healthcare Triangle, Inc. |
|
| January 2, 2024 |
PLEDGE AGREEMENT THIS PLEDGE AGREEMENT made as of December 28, 2023 (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), by Healthcare Triangle, Inc. |
|
| January 2, 2024 |
THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR UPON RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT. |
|
| January 2, 2024 |
SECURITY AGREEMENT THIS SECURITY AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) dated as of December 28, 2023, between Healthcare Triangle, Inc. |
|
| November 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 29, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| November 29, 2023 |
HEALTHCARE TRIANGLE, INC. CLAWBACK POLICY Introduction The Board of Directors (“Board”) of Healthcare Triangle, Inc. (the “Company”) believes that it is in the best interests of the Company and its shareholders to adopt this policy which provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial repor |
|
| November 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| September 5, 2023 |
Consulting Agreement between the Company and Paige Heaphy, dated as of September 1, 2023 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is made this September 1, 2023, to be effective upon the earlier of (1) September 1, 2023; or (2) the date their replacement is appointed as a member of the Board (which date will be the “Effective Date”), by and between Healthcare Triangle, Inc. |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 1, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC. |
|
| July 14, 2023 |
Dave Rosa 9705 Emerson Court Eden Prairie, MN 55347 July 13, 2023 RE: Healthcare Triangle, Inc. |
|
| July 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 13, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| June 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 23, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| June 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 31, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F |
|
| May 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 25, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F |
|
| May 30, 2023 |
Certificate of Amendment to the Certificate of Incorporation of Healthcare Triangle, Inc. CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF HEALTHCARE TRIANGLE, INC. |
|
| May 30, 2023 |
Healthcare Triangle, Inc. Announces 1-for-10 Reverse Stock Split as Part of Nasdaq Compliance Plan Healthcare Triangle, Inc. Announces 1-for-10 Reverse Stock Split as Part of Nasdaq Compliance Plan PLEASANTON, Calif., May 25, 2023 (GLOBENEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today announced that it w |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 1, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| April 6, 2023 |
SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of April 05, 2023, by and between Healthcare Triangle Inc. |
|
| April 6, 2023 |
Employment Agreement THIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between HEALTHCARE TRIANGLE, INC. |
|
| April 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 1, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| March 28, 2023 |
HEALTHCARE TRIANGLE INC. MASTER SERVICES AGREEMENT THIS Master Services Agreement (the “Agreement”) is entered into as of 01 January, 2021 (the “Effective Date”) by and between by and between Healthcare Triangle Inc., a Nevada corporation having its principal place of business 4309 Hacienda Dr, Suite 150, Pleasanton, CA 94588, (the “Company”) and Securekloud Technologies Inc., a Nevada corporation |
|
| March 28, 2023 |
Rental Sub-Lease Agreement Securekloud Technologies, Inc. This Rental Sub-Lease Agreement (this “Sub-Lease Agreement”) is made and entered into effect as of January 1st, 2021 by and between Securekloud Technologies, Inc. (“Tenant”) and Health Care Triangle, Inc. (“Sub-Tenant”). Recitals A. Tenant and Sub-Tenant executed that certain real property sub-lease dated January 1st, 2021 (collectively, th |
|
| March 28, 2023 |
HEALTHCARE TRIANGLE INC. SHARED SERVICES AGREEMENT This SHARED SERVICES AGREEMENT (the “Agreement”), is entered into on January 1, 2021 (the “Effective Date”), by and between Securekloud Technologies Inc., a Nevada corporation and Healthcare Triangle Inc., a Nevada corporation, (the “Company”). Securekloud Technologies Inc and the Company are hereinafter sometimes referred to collectively as the “ |
|
| March 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40903 HEALTHCARE TRIANG |
|
| January 27, 2023 |
January 5,2023 Roy Sookhoo 1504 Cereza Drive SE Rio Rancho, NM 87124 Dear Roy, Healthcare Triangle Inc. |
|
| January 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 25, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi |
|
| January 27, 2023 |
' 9FvF # # ;. L2fLHy = bLElbHELfEs^lLHyq gtRy+cLElbHELgEtmLHyq ./+")7')8; 880; 1')8 %7!2; &") % ; );,3;, ; #4 9-46; 2MF ;. L2fLHy =( AM FM}nMFMK { Mnn{ dF dM -{FK {N 2hMJ{ dM -{FK {N6MFndJFM @hFvanM 7vJ dM /{r}Fv dF MnMJMK { {MM FF ( 4; - ;9! ; -4; *; !$5 |
|
| January 27, 2023 |
EX-99.3 9 ex993.htm EXHIBIT 99.3 January 25, 2023 Roy Sookhoo 1504 Cereza Drive, SE Rio Rancho, NM 87124 Dear Roy, This letter will serve as an amendment to your original offer letter dated January 5, 2023. Itemized below are the proposed terms of our offer: 1. Your start date has been changed to January 25, 2023. As Chief Operating Officer and a full time, permanent employee, your base salary wil |
|
| January 27, 2023 |
January 25, 2023 Roy Sookhoo 1504 Cereza Drive, SE Rio Rancho, NM 87124 Dear Roy, This letter will serve as an amendment to your original offer letter dated January 5, 2023. |
|
| January 27, 2023 |
January 25, 2023 Roy Sookhoo 1504 Cereza Drive, SE Rio Rancho, NM 87124 Dear Roy, This letter will serve as an amendment to your original offer letter dated January 5, 2023. |
|
| January 27, 2023 |
' 9FvF # # ;. L2fLHy = bLElbHELfEs^lLHyq gtRy+cLElbHELgEtmLHyq ./+")7')8; 880; 1')8 %7!2; &") % ; );,3;, ; #4 9-46; 2MF ;. L2fLHy =( AM FM}nMFMK { Mnn{ dF dM -{FK {N 2hMJ{ dM -{FK {N6MFndJFM @hFvanM 7vJ dM /{r}Fv dF MnMJMK { {MM FF ( 4; - ;9! ; -4; *; !$5 |
|
| January 27, 2023 |
January 5,2023 Roy Sookhoo 1504 Cereza Drive SE Rio Rancho, NM 87124 Dear Roy, Healthcare Triangle Inc. |
|
| January 27, 2023 |
Appointment Letter Agreement- Healthcare Triangle, Inc. Board of Directors January 23, 2023 [New Director], Appointment Letter Agreement- Healthcare Triangle, Inc. |
|
| January 27, 2023 |
January 5,2023 Roy Sookhoo 1504 Cereza Drive SE Rio Rancho, NM 87124 Dear Roy, Healthcare Triangle Inc. |
|
| December 30, 2022 |
CE RTIFIED PUBLIC ACCOUNTANTS Fl FOUNDL\TION INDEPEI-JDENTLY O\NNEO ME1v18En December 30, 2022 U. |
|
| December 30, 2022 |
By Electronic Delivery to: [email protected]; [email protected] December 29, 2022 Mr. Thyagarajan Ramachandran Chief Financial Officer Healthcare Triangle, Inc. 7901 Stoneridge Dr., Suite 220 Pleasanton, CA 94588 Re: Healthcare Triangle, Inc. (the “Company”) Nasdaq Symbol: HCTI Dear Mr. Ramachandran: As you are aware, due to the resignations of Mr. Jeffrey S. Mathiesen, Mr. John Leo and M |
|
| December 30, 2022 |
Resignation Letter from Ram Associates to the Company dated December 27, 2022. December 27, 2022 President and Board of Directors of Healthcare Triangle Inc 4309 Hacienda Dr, Suite 150 Pleasanton, CA 94588 Effective December 27, 2022, we will cease our services as your accountants. |
|
| December 30, 2022 |
Letter to the Securities and Exchange Commission from Ram Associates dated December 30, 2022. December 30, 2022 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 We have read the statements under Item 4.01 of the Current Report on Form 8-K of Healthcare Triangle, Inc. to be filed with the Securities and Exchange Commission on or about December 30, 2022. We agree with all statements pertaining to us. We have no basis on which to agree or disagree with the other |
|
| December 30, 2022 | ||
| December 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 29, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| December 23, 2022 |
Resignation Letter from April Bjornstad dated December 23, 2022. December 23, 2022 VIA EMAIL Board of Directors Healthcare Triangle, Inc. Dear Board members: I regret to inform you that I hereby resign from the Board of Directors and all committees of Healthcare Triangle, Inc. effective immediately. In light of the recent developments brought to the a?en?on of the Board on December 21, 2022, I will no longer be able serve on the Board or any committees. My resi |
|
| December 23, 2022 |
Resignation Letter from John Leo dated December 23, 2022. December 23, 2022 VIA EMAIL Board of Directors Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 Dear Board members: I regret to inform you that I hereby resign from the Board of Directors and all committees of Healthcare Triangle, Inc. effective immediately. In light of the recent developments brought to the attention of the Board I will no longer be able serve on th |
|
| December 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 19, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| December 23, 2022 |
Resignation Letter from Jeffrey S. Mathiesen dated December 23, 2022. December 23, 2022 VIA EMAIL Board of Directors Healthcare Triangle, Inc. Dear Board members: I regret to inform you that I hereby resign from the Board of Directors and all committees of Healthcare Triangle, Inc., effectively immediately. In light of the recent developments, I have determined that I will no longer be able to effectively serve in the Board capacity and committee positions. My resig |
|
| November 21, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 17, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss |
|
| November 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, |
|
| October 19, 2022 |
DEF 14A 1 hcti101422def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as |
|
| October 19, 2022 |
Dear Shareholders, Colleagues, Customers, and Business Partners: Thank you for your commitment and investment in Healthcare Triangle, Inc. |
|
| October 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| August 18, 2022 |
As filed with to the Securities and Exchange Commission on August 18, 2022 As filed with to the Securities and Exchange Commission on August 18, 2022 Registration No. |
|
| August 18, 2022 |
Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 CORRESP 1 filename1.htm Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 August 18, 2022 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC. 20549 Attn: Alexandra Barone Re: Healthcare Triangle, Inc. Registration Statement on Form S-1 File No. 333-266952 Ms. Barone: Pursuant to Rule 461 of the General Rules and Regulations under the S |
|
| August 18, 2022 |
As filed with to the Securities and Exchange Commission on August 18, 2022 As filed with to the Securities and Exchange Commission on August 18, 2022 Registration No. |
|
| August 18, 2022 |
EX-FILING FEES 3 ex107.htm FILING FEES TABLE Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Healthcare Triangle, Inc. (Exact Name of Registrant as Specified in its Charter) Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fee |
|
| August 15, 2022 |
United States securities and exchange commission logo August 15, 2022 Suresh Venkatachari Chief Executive Officer Healthcare Triangle, Inc. |
|
| August 9, 2022 |
As confidentially submitted to the Securities and Exchange Commission on August 9, 2022 DRS 1 filename1.htm As confidentially submitted to the Securities and Exchange Commission on August 9, 2022 Registration No. 333-[ ] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 7373 84-3559776 (State or other jurisdic |
|
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC. |
|
| July 13, 2022 |
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. |
|
| July 13, 2022 |
Healthcare Triangle Announces $6.5 Million Private Placement Healthcare Triangle Announces $6.5 Million Private Placement PLEASANTON, Calif., July 11, 2022 (GLOBE NEWSWIRE) ? Healthcare Triangle Inc., (Nasdaq: HCTI) (?HCTI? or the ?Company?), a leading provider of cloud and data transformation solutions for healthcare and life sciences, today announced that it has entered into a definitive agreement with a single institutional investor for the issuance and |
|
| July 13, 2022 |
EXHIBIT B REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is made and entered into as of July 10, 2022, by and between Healthcare Triangle, Inc. |
|
| July 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 10, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission |
|
| July 13, 2022 |
SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of July 10, 2022, between Healthcare Triangle, Inc. |
|
| July 13, 2022 |
Form of Placement Agent Preferred Investment Option, dated July 13, 202(4) NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. |
|
| July 13, 2022 |
Healthcare Triangle Announces Closing of $6.5 Million Private Placement Healthcare Triangle Announces Closing of $6.5 Million Private Placement PLEASANTON, Calif., July 13, 2022 (GLOBE NEWSWIRE) ? Healthcare Triangle Inc., (Nasdaq: HCTI) (?HCTI? or the ?Company?), a leading provider of cloud and data transformation solutions for healthcare and life sciences, today announced the closing of its previously announced private placement with a single institutional investor |
|
| July 13, 2022 |
Pre-Funded Warrant, dated as of July 13, 2022, by and between the Company and the Purchase(4) NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. |
|
| June 10, 2022 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 3, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F |
|
| May 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 26, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC |
|
| April 1, 2022 |
Appointment Letter Agreement between the Company and Jeffrey S. Mathiesen, dated March 31, 2022 EX-10.1 2 ex101.htm EXHIBIT 10.1 March 31, 2022 Jeffrey S. Mathiesen 12784 Kinross Ln Naples, FL 34120 Appointment Letter Agreement – Healthcare Triangle, Inc. Board of Directors Dear Jeff: We are pleased to tell you that the Board of Directors (the “Board”) of Healthcare Triangle, Inc. (the “Company”) has elected you to serve as a member of the Board commencing from March 31, 2022. 1. Your Duties |
|
| April 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 30, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of (Commission (IRS Employer |
